Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Balance Sheet 2016–2025
| Dec 2025 | Dec 2024 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 140.7M | 60.3M | 13.4M | 7.3M | 9.9M | 2.9M |
| Cash & Equivalents | 61.8M | 45.8M | 13.2M | 6.9M | 9.0M | 2.1M |
| Liabilities | ||||||
| Total Liabilities | 2.9M | 5.3M | 724,165 | 399,551 | 311,867 | 64,510 |
| Long-Term Debt | — | — | — | — | — | — |
| Equity | ||||||
| Shareholders' Equity | 137.8M | 55.0M | 12.6M | 6.9M | 9.6M | 2.8M |
Monopar Therapeutics Inc. Balance Sheet — FAQ
Monopar Therapeutics Inc. (MNPR) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNPR's balance sheet history?
The chart and table above show Monopar Therapeutics Inc.'s balance sheet by year and by quarter, including the growth rate.